GridAI Technologies (GRDX) Common Equity (2015 - 2026)
GridAI Technologies' (GRDX) quarterly Common Equity came in at $14.9 million in Q2 2026, up 336.23% on a YoY basis from $3.4 million in Q2 2025, and down 40.35% quarter-over-quarter from $24.9 million in Q4 2025.
Analysis
GridAI Technologies (GRDX) Common Equity (2015 - 2026) Analysis & Trends
GridAI Technologies (GRDX) has reported Common Equity for 12 consecutive years, with $14.9 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Common Equity rose 336.23% year-over-year to $14.9 million; the trailing twelve-month figure through Jun 2026 stood at $14.9 million (up 336.23% YoY), and the FY2025 full-year result was $24.9 million, up 743.4% from the prior year.
- Common Equity fell to $14.9 million in Q2 2026 per GRDX's latest filing, from $24.9 million in the prior quarter.
- Across five years, Common Equity topped out at $50.0 million in Q3 2022 and bottomed at -$14.2 million in Q2 2022.
- Historically, Common Equity has averaged $7.4 million across 5 years, with a median of $3.3 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Common Equity tumbled 301.65% in 2022, then soared 934.13% in 2024.
- Over 5 years, Common Equity stood at $2.7 million in 2022, then jumped by 31.39% to $3.6 million in 2023, then tumbled by 207.6% to -$3.9 million in 2024, then jumped by 743.4% to $24.9 million in 2025, then slumped by 40.35% to $14.9 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $14.9 million, $24.9 million, and $27.9 million for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.74 Bn | 192.75 Bn | 7.24 Bn | 11.69 Bn |
| 2 | Gilead Sciences | 179.96 Bn | 176.78 Bn | 6.22 Bn | 11.83 Bn |
| 3 | Vertex Pharmaceuticals | 131.20 Bn | 123.35 Bn | 2.84 Bn | 20.25 Bn |
| 4 | Regeneron Pharmaceuticals | 82.05 Bn | 74.05 Bn | 3.93 Bn | 31.71 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn | 8.42 Bn |
| 6 | Moderna | 53.67 Bn | 48.54 Bn | 52.00 Mn | 6.76 Bn |
| 7 | Alnylam Pharmaceuticals | 33.08 Bn | 29.78 Bn | 992.69 Mn | 1.35 Bn |
| 8 | Biogen | 31.91 Bn | 30.62 Bn | 1.96 Bn | 18.85 Bn |
| 9 | Roivant Sciences | 29.22 Bn | 29.22 Bn | 1.16 Mn | 4.92 Bn |
| 10 | GridAI Technologies | 18.97 Mn | 18.97 Mn | -36,514.00 | 14.88 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.88 Mn |
| Dec 31, 2025 | 24.94 Mn |
| Sep 30, 2025 | 27.88 Mn |
| Jun 30, 2025 | -6.30 Mn |
| Mar 31, 2025 | -5.22 Mn |
| Dec 31, 2024 | -3.88 Mn |
| Sep 30, 2024 | 8.37 Mn |
| Jun 30, 2024 | 9.12 Mn |
| Mar 31, 2024 | 16.18 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 3.28 Mn |
| Jun 30, 2023 | 881,960.00 |
| Mar 31, 2023 | 2.71 Mn |
| Dec 31, 2022 | 2.74 Mn |
| Sep 30, 2022 | 50.00 Mn |
| Jun 30, 2022 | -14.19 Mn |
| Mar 31, 2022 | -9.24 Mn |
| Dec 31, 2021 | -7.82 Mn |
| Sep 30, 2021 | -6.97 Mn |
| Jun 30, 2021 | 7.04 Mn |